UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                   Form 10-KSB

--------------------------------------------------------------------------------

(Mark one)

    XX          ANNUAL  REPORT  UNDER  SECTION  13 OR  15(d) OF  THE  SECURITIES
----------      EXCHANGE ACT OF 1934

                      For the annual period ended December 31, 2000

                TRANSITION REPORT UNDER SECTION 13 OR 15(d)  OF  THE  SECURITIES
-----------     EXCHANGE ACT OF 1934

                      For the transition period from ____________to ____________


--------------------------------------------------------------------------------


                         Commission File Number: 2-90519
                                                 -------

                          ProHealth Laboratories, Inc.
        (Exact name of small business issuer as specified in its charter)

          Nevada                                               59-2262718
--------------------------                            --------------------------
 (State of incorporation)                              (IRS Employer ID Number)

                  211 West Wall Street, Midland, TX 70701-4556
                  --------------------------------------------
                    (Address of principal executive offices)

                                 (915) 682-1761
                                 --------------
                           (Issuer's telephone number)

                           DCC Acquisition Corporation
             1201 Chester Industrial Parkway, Avon, Ohio 44011-1081
             ------------------------------------------------------
                    (Former name, former address and former
                   fiscal year, if changed since last report)

--------------------------------------------------------------------------------


      Securities registered under Section 12 (b) of the Exchange Act: None

         Securities registered under Section 12(g) of the Exchange Act:

                         Common Stock $0.0001 par value

Check whether the issuer has (1) filed all reports required to be files by
Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such
shorter period the Company was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. Yes    No X
                                                             ---   ---

Check if there is no disclosure of delinquent  filers in response to Item 405 of
Regulation S-B contained in this form, and no disclosure  will be contained,  to
the best of Company's knowledge,  in definitive proxy or information  statements
incorporated  by reference  in Part III of this Form 10-KSB or any  amendment to
this Form 10-KSB. [ ]

The issuer's revenues for the fiscal year ended December 31, 2000 were $0.

As of April 30, 2001, the aggregate  market value of the Company's  common Stock
held by non-affiliates was: $-0-

As of April 30,  2001,  there were  152,247  shares of Common  Stock  issued and
outstanding.

Transitional Small Business Disclosure Format : Yes    No X
                                                   ---   ---

                                                                               1



                                TABLE OF CONTENTS



                                                                           Page
                                                                          Number
                                                                          ------
Part I

Item  1 - Description of Business                                            3
Item  2 - Description of Property                                            4
Item  3 - Legal Proceedings                                                  4
Item  4 - Submission of Matters to a Vote of Security Holders                4

Part II

Item  5 - Market for Company's Common Stock and Related
           Stockholders Matters                                              5
Item  6 - Management's Discussion and Analysis or Plan of Operation          6
Item  7 - Index to Financial Statements                                     F-1
Item  8 - Changes in and Disagreements with Accountants
           on Accounting and Financial Disclosures                           6

Part III

Item  9 - Officers and Directors                                             6
Item 10 - Executive Compensation                                             7
Item 11 - Security Ownership of Certain Beneficial Owners And Management     7
Item 12 - Certain Relationships and Related Transactions                     8
Item 13 - Exhibits and Reports on 8-K                                        9

Signatures                                                                  10




                                                                               2



                  Caution Regarding Forward-Looking Information
                  ---------------------------------------------

This annual report contains certain  forward-looking  statements and information
relating  to the  Company  that  are  based on the  beliefs  of the  Company  or
management as well as assumptions made by and information currently available to
the Company or management.  When used in this document,  the words "anticipate",
"believe",  "estimate",  "expect" and "intend" and similar expressions,  as they
relate  to  the   Company  or  its   management,   are   intended   to  identify
forward-looking  statements.  Such  statements  reflect the current  view of the
Company regarding future events and are subject to certain risks,  uncertainties
and assumptions, including the risks and uncertainties noted. Should one or more
of these risks or uncertainties  materialize,  or should underlying  assumptions
prove incorrect,  actual results may vary materially from those described herein
as anticipated,  believed,  estimated,  expected or intended.  In each instance,
forward-looking  information  should be considered in light of the  accompanying
meaningful cautionary statements herein.


PART I

Item 1 - Description of Business

General
-------

Datalink Systems,  Inc. (Datalink) filed a registration under The Securities Act
of 1933 on Form S-1 with the Securities and Exchange  Commission with respect to
a public offering of its securities.  The offering became  effective on July 29,
1985 and completed October 29, 1985 and raised an aggregate of $300,000 from the
sale of 3,000,000 shares of common stock at $.10 per share.

The Company was engaged in the  business  of  providing  electronic  information
processing  services to the medical/health  care industry.  This venture was not
successful and management attempted to redirect the focus of the company through
merger with a viable private  entity.  Several Letters of Intent were signed but
later abandoned by all parties.

The corporate name was changed in April 29, 1987 to Datalink Capital Corporation
and the capital restated to 100,000,000 shares of $.0001 par value common stock.

The  corporate  charter  was revoked on November 4, 1988 by the State of Florida
for failure to file required documents and pay associated fees.

A change in control of the majority  stockholder resulted in a change in control
of the Company and the company's  charter was reestablished on December 5, 1990.
The new  management  was unable to  complete a merger  with a private  entity or
recapitalize the company and the company remained dormant. On April 26, 1991 the
corporate name was changed to Midland Capital Resources, Inc.

The  corporate  charter  was  revoked  again on  October 9, 1992 by the State of
Florida for failure to file required  documents and pay associated fees. On July
30, 1997,  the charter was  reinstated  by the State of Florida and on September
24, 1997 the name was changed to Datalink Capital Corporation.

On May 1, 1997 a stock  purchase  agreement  was entered  into  between the then
majority  stockholder  and Glenn A. Little.  In March 1998,  this  agreement was
renegotiated and effective  control of the company was obtained by Mr. Little by
the purchase of 37.4% of the outstanding shares.

Effective  December 29, 1998 the Company changed its state of incorporation from
Florida to Nevada, pursuant to a change-of-state-if-incorporation merger. In the
merger  transaction,  the  Company's  name was changed  from  "DataLink  Capital
Corporation" to "DCC Acquisition Corporation".

On June 8, 1999,  in a Current  Report on Form 8-K,  the Company  announced  its
acquisition  of all of the issued and  outstanding  common  shares of New Cinema
Partners Inc. (NCP) in  consideration of and in exchange for common stock of the
Company  issued  from  treasury  (Acquisition  Transaction),  which  transaction
constituted a change in control of the Company.

                                                                               3



On August 15, 1999,  the Company  filed a Current  Report on Form 8-K  reporting
that the June 8, 1999 Form 8-K  announcement of the Acquisition  Transaction and
the filing of the June 8, 1999 Form 8-K  Current  Report in respect  thereof was
premature.   The  Acquisition  Transaction  had  not  been,  and  will  not  be,
consummated. The Board of Directors of the Company did not approve, authorize or
ratify  the   Acquisition   Transaction.   Due  to   mis-communication   between
representatives  of NCP and its shareholders and the agent for the Company,  NCP
and  its  shareholders  were  of the  view  that  all  requisite  approvals  and
authorizations  in respect of the Acquisition  Transaction had been obtained and
all other conditions precedent to the completion of the Acquisition  Transaction
satisfied  and,  accordingly,  the Jun e8, 1999  Current  Report on Form 8-K was
filed in accordance with applicable law.

The  Company  continued  its  efforts to locate and  combine  with an  existing,
privately-held  company that is profitable or, in management's  view, has growth
potential, irrespective of the industry in which it is engaged.

On November 17,  1999,  in the  Quarterly  Report on Form 10-QSB for the quarter
ended  September 30, 1999,  the Company  announced that on November 1, 1999, the
Company experienced a change in control and acquired a majority of the shares of
stock of two  corporations,  ProHealth  Laboratories,  Inc  (ProHealth)  and STL
Group, Inc. (STL) in exchange for shares of the Company's common stock. Although
discussed in the November 17, 1999 Form 10-QSB  filing,  the Company never filed
any  required   Current  Report  on  Form  8-K  which  contained  more  detailed
information  about the terms of the  acquisitions of ProHealth and STL and their
business and financial information.

On January 11, 2001,  the Company filed a Current  Report on Form 8-K announcing
that the two Agreements and Plans of Reorganization  (Agreements)  disclosed and
discussed  in the  November  17,  1999  Form  10-QSB  filing  never  closed  and
prematurely announced as such.

In anticipation  of the closing of these  transaction and in accordance with the
Agreements,  the Company  convened a Board of  Directors  Meeting on October 22,
1999  and  changed  the name  from DCC  Acquisition  Corp to  ProHealth  Medical
Technologies,  Inc. and approved and enacted a 1:10 reverse  split of its Common
Stock, $0.0001 par value, with fractional shares rounded up to the nearest whole
share.  All share and per share amounts in this filing reflect the effect of the
reverse split as of the first day of the first period presented.

As a result of each of the private entity's inability to fulfill its obligations
under each Agreement with the Company, the closing of the acquisitions has never
taken place as planned and announced.

In January  2001,  Glenn A. Little and Matthew  Blair,  the former  officers and
directors  of  the  Company,  reached  an  agreement  with  the  parties  to the
Agreements  to  recognize  the  failure  of the  merger  and agreed to return as
Management  of the Company.  All books and records  were  returned to the former
management  of  the  Company  and  the  various  companies  and  parties  to the
Agreements mutually released and discharged each other with regard to the failed
transaction.

Pursuant to the  rescission  agreement,  any and all shares  which may have been
issued  pursuant to the Agreements  were rescinded and returned to the Company's
treasury,  and the Company  appointed  Glenn A. Little as President and Director
and Matthew Blair as Secretary and Director.

It is the intention of the current management to bring its SEC reporting to date
in order that the Company might be potentially  attractive to a private business
that might be  interested  in  becoming a  publicly-held  company,  without  the
expense and time delay involved in distributing its securities to the public.

Proposed Business
-----------------

The  Company  intends to locate and  combine  with an  existing,  privately-held
company which is profitable  or, in  management's  view,  has growth  potential,
irrespective of the industry in which it is engaged.  However,  the Company does
not  intend  to  combine  with a  private  company  which may be deemed to be an
investment  company subject to the Investment Company Act of 1940. A combination
may be structured as a merger,  consolidation,  exchange of the Company's common
stock for stock or assets or any other form which  will  result in the  combined
enterprise's becoming a publicly-held corporation.


                                                                               4



Pending  negotiation and consummation of a combination,  the Company anticipates
that it will have, aside from carrying on its search for a combination  partner,
no business  activities,  and, thus, will have no source of revenue.  Should the
Company incur any significant  liabilities prior to a combination with a private
company, it may not be able to satisfy such liabilities as are incurred.

If the Company's management pursues one or more combination opportunities beyond
the  preliminary  negotiations  stage and those  negotiations  are  subsequently
terminated,  it is  foreseeable  that such efforts  will  exhaust the  Company's
ability to continue to seek such combination opportunities before any successful
combination can be consummated.  In that event,  the Company's common stock will
become  worthless  and  holders of the  Company's  common  stock will  receive a
nominal distribution, if any, upon the Company's liquidation and dissolution.

Combination Suitability Standards
---------------------------------

In its pursuit for a combination  partner,  the Company's  management intends to
consider only  combination  candidates  which are profitable or, in management's
view, have growth potential.  The Company's management does not intend to pursue
any  combination  proposal  beyond the  preliminary  negotiation  stage with any
combination  candidate which does not furnish the Company with audited financial
statements  for at least its most  recent  fiscal year and  unaudited  financial
statements for interim periods  subsequent to the date of such audited financial
statements, or is in a position to provide such financial statements in a timely
manner.  The Company will, if necessary  funds are available,  engage  attorneys
and/or accountants in its efforts to investigate a combination  candidate and to
consummate a business  combination.  The Company may require  payment of fees by
such combination  candidate to fund the investigation of such candidate.  In the
event such a combination candidate is engaged in a high technology business, the
Company may also obtain  reports from  independent  organizations  of recognized
standing  covering the technology  being developed and/or used by the candidate.
The  Company's  limited  financial  resources may make the  acquisition  of such
reports  difficult  or even  impossible  to obtain  and,  thus,  there can be no
assurance  that the Company  will have  sufficient  funds to obtain such reports
when considering combination proposals or candidates.  To the extent the Company
is  unable to  obtain  the  advice or  reports  from  experts,  the risks of any
combined enterprise's being unsuccessful will be enhanced.  Furthermore,  to the
knowledge of the Company's officers and directors, neither the candidate nor any
of  its  directors,   executive  officers,  principal  shareholders  or  general
partners:

    (1) will not have been convicted of securities fraud, mail fraud, tax fraud,
        embezzlement,   bribery,   or  a  similar  criminal  offense   involving
        misappropriation  or theft of  funds,  or be the  subject  of a  pending
        investigation or indictment involving any of those offenses;

    (2) will not have been  subject to a temporary or  permanent  injunction  or
        restraining  order arising from  unlawful  transactions  in  securities,
        whether as issuer,  underwriter,  broker, dealer, or investment advisor,
        may be the subject of any  pending  investigation  or a  defendant  in a
        pending  lawsuit  arising  from or based upon  allegations  of  unlawful
        transactions in securities; or

    (3) will not have been a defendant  in a civil  action  which  resulted in a
        final judgement  against it or him awarding  damages or rescission based
        upon unlawful practices or sales of securities.

The Company's  officers and directors will make these  determinations  by asking
pertinent  questions of the  management of prospective  combination  candidates.
Such persons will also ask pertinent  questions of others who may be involved in
the combination proceedings.  However, the officers and directors of the Company
will not generally take other steps to verify independently information obtained
in this manner which is favorable.  Unless  something  comes to their  attention
which  puts  them on  notice  of a  possible  disqualification  which  is  being
concealed  from them,  such persons will rely on  information  received from the
management of the prospective  combination  candidate and from others who may be
involved in the combination proceedings.

Governmental Regulation
-----------------------

It is  impossible  to predict the  government  regulation,  if any, to which the
Company may be subject.  The use of assets and/or conduct of businesses that the
Company may operate within could subject it to environmental,  public health and
safety,  land use, trade, or other  governmental  regulations and state or local
taxation. Management will endeavor to ascertain and monitor the effects of such,
if any,  government  regulation  on the  business  of the  Company.  In  certain
circumstances,  however,  it may not be possible  to predict  with any degree of
accuracy the impact of  government  regulation.  The  inability to ascertain the
effect of government  regulation on a particular business activity will make the
acquisition of an interest in such business a higher risk.

                                                                               5



Competition
-----------

The Company may be involved in intense competition with other business entities,
many of which could have a competitive  edge over the Company by virtue of their
stronger  financial  resources  and prior  experience  in business.  There is no
assurance  that  the  Company  will  be  successful  in a  competitive  business
environment.

Employees
---------

The Company currently has no employees.  The sole executive officer,  who is not
compensated for his time  contributed to the Company,  devotes only such time to
the affairs of the Company, which is minimal at this time.


Item 2 - Description of Properties

The Company has no properties and has no requirement  for property or offices at
this time. The Company's records require nominal space and are maintained in the
offices of it's  President at 211 West Wall Street,  Midland,  Texas 79701 at no
charge.


Item 3 - Legal Proceedings

The Company is not a party to any material pending legal proceedings, and to the
best of its knowledge,  no such  proceedings by or against the Company have been
threatened.


Item 4 - Submission of Matters to a Vote of Security Holders

No matter was submitted to a vote of security  holders in the fiscal years ended
December 31, 1999 and 2000, respectively.


PART II

Item 5 - Market for Common Equity and Related Stockholder Matters

Market Information
------------------

The Company's  common stock is not listed for trading on any electronic board or
other exchange.

As of April 30,  2001,  there were  approximately  400  holders on record of the
Company's common stock holding a total of 152,247 shares.

Dividend Policy
---------------

The Company has never paid any  dividends  on its common stock and does not have
any current plan to pay any dividends in the foreseeable future.



                (Remainder of this page left blank intentionally)




                                                                               6



Item 6 - Management's Discussion and Analysis of Financial Condition, Results of
Operations and Plan of Operation

Results of Operations
---------------------

Years Ended December 31, 2000 and 1999
--------------------------------------

The Company had no revenue for the years ended December 31, 2000 and 1999.

General and  administrative  expenses for the years ended  December 31, 2000 and
1999  were   approximately   $5,720  and  $3,350,   respectively.   General  and
administrative  expenses  during  these  years  consisted  principally  of  fees
associated with the maintenance of the Company's shareholder ledger. The Company
realized a net loss of  approximately  $5,720  and  $3,350  for the years  ended
December 31, 2000 and 1999, respectively.

The  Company  does not  expect  to  generate  any  meaningful  revenue  or incur
operating  expenses  unless  and until  such time that the  Company's  operating
subsidiary begins meaningful operations.

Liquidity and Capital Resources
-------------------------------

At December 31, 2000, and for all periods  subsequent  thereto,  the Company had
working capital of $-0-.

It  is  the  intent  of  management  and  significant  stockholders  to  provide
sufficient  working  capital  necessary to support and preserve the integrity of
the  corporate  entity.  However,  there  is  no  legal  obligation  for  either
management or significant  stockholders  to provide  additional  future funding.
Should this pledge fail to provide financing, the Company has not identified any
alternative  sources.  Consequently,   there  is  substantial  doubt  about  the
Company's ability to continue as a going concern.

The  Company's  need for  capital  may  change  dramatically  as a result of any
business acquisition or combination transaction.  There can be no assurance that
the Company will  identify any such  business,  product,  technology  or company
suitable for acquisition in the future.  Further, there can be no assurance that
the Company would be successful in  consummating  any  acquisition  on favorable
terms  or that it will be able  to  profitably  manage  the  business,  product,
technology or company it acquires.


Item 7 - Financial Statements

The  financial  statements  of the  Company  appear  at the end of  this  report
beginning with the Index to Financial Statements on page F-1.


Item 8 -  Changes  in and  Disagreements  with  Accountants  on  Accounting  and
Financial Disclosure

On December 15, 1999,  the Company filed a Current Report on Form 8-K announcing
that S. W. Hatfield,  C.P.A., formerly S. W. Hatfield & Associates, had resigned
as the Company's  independent auditor as a result of the announced  acquisitions
of ProHealth  Laboratories,  Inc (ProHealth)  and STL Group,  Inc. This document
announced the appointment of Wrabel & Company to be the successor firm. Although
interviews  with Wrabel & Company  took place,  the  Company  never  executed an
engagement  letter with Wrabel & Company and the disclosure by former management
of the  engagement  of Wrabel & Company by the Company was  premature.  Wrabel &
Company  never  performed  any  services  of any  type for the  Company  between
December 15, 1999 and April 6, 2001.

On April 6, 2001,  as a result of the change in  control of the  Company,  S. W.
Hatfield CPA  accepted  reappointment  as the  Company's  independent  certified
public  accounting firm to audit the Company's  financial  statements  beginning
with the year ending  December  31, 1999 and to review the  Company's  quarterly
filings beginning with the quarter ended March 31, 2000.



                                                                               7



Between the period of December  15, 1999 and April 6, 2001,  the Company held no
discussions with S. W. Hatfield,  CPA on any matter of accounting  principals or
practices, financial statement disclosure or accounting scope or procedure.

Additionally,  there  were and have been no  changes  in or  disagreements  with
accountants  reporting on the financial statements of the Company for the period
between December 31, 1998 and the date of this filing.


PART III

Item  9  -  Directors,   Executive  Officers,  Promoters  and  Control  Persons;
Compliance with Section 16(A) of The Securities Exchange Act of 1934

Directors and Officers
----------------------

The following  table sets forth the names,  ages, and positions with the Company
for the sole director and officer of the Company.

    Name                   Age          Position Held and Tenure
    ----                   ---          ------------------------

Glenn Little               47             President, Director
Matthew Blair              43        Secretary, Treasurer Director

The  directors  named  above will  serve  until the next  annual  meeting of the
Company's  stockholders  or until  their  successors  are duly  elected and have
qualified.   Directors  will  be  elected  for  one-year  terms  at  the  annual
stockholders meeting.  Officers will hold their positions at the pleasure of the
board of directors,  absent any  employment  agreement,  of which none currently
exists or is contemplated.  There is no arrangement or understanding between any
of the  directors  or officers of the Company and any other  person  pursuant to
which any director or officer was or is to be selected as a director or officer,
and there is no arrangement,  plan or understanding as to whether non-management
shareholders  will exercise their voting rights to continue to elect the current
directors to the Company's board. There are also no arrangements,  agreements or
understandings  between   non-management   shareholders  that  may  directly  or
indirectly participate in or influence the management of the Company's affairs.

The directors and officers will devote their time to the Company's affairs on an
as needed  basis,  which,  depending  on the  circumstances,  could amount to as
little as two hours per month, or more than forty hours per month, but more than
likely will fall  within the range of five to ten hours per month.  There are no
agreements  or  understandings  for any  officer  or  director  to resign at the
request of another  person,  and none of the officers or directors are acting on
behalf of, or will act at the direction of, any other person.

Biographical Information

Glenn A.  Little,  is a  graduate  of The  University  of  Florida,  Gainesville
(Bachelor  of Science in  Business  Administration)  and the  American  Graduate
School of International  Management  (Master  International  Management) and has
been the  principal  of Little and  Company  Investment  Securities  (LITCO),  a
Securities  Broker/Dealer with offices in Midland,  Texas since 1979. Mr. Little
currently serves as an officer of other inactive public  corporations having the
same business purpose as the Company.

Before founding LITCO, Mr. Little was a stockbroker with Howard, Weil, Labouisse
Friedrich in New Orleans and Midland and worked for the First  National  Bank of
Commerce in New Orleans, Louisiana.

Matthew Blair was formerly a solo  practitioner of law in Midland,  Texas and is
presently  a Title IV-D  Master in Midland  County  Texas.  Before  opening  his
practice  he served in the Legal  Department  of the Federal  Deposit  Insurance
Corporation  (FDIC),  Midland,  Texas  where he  gained  exposure  to  corporate
structures and debt workouts.  His employment  before the FDIC  appointment  was
with Texas American Energy and Exxon Corporation.  Mr. Blair received a Bachelor
of Arts in  Government  from The  University of Texas at Austin (1975) and Juris
Doctor from Texas Tech University  School of Law (1979). He is licensed in every
state court in Texas,  United  States  District  Court (Texas) and in The United
States Supreme Court.

                                                                               8



Item 10 - Executive Compensation

There was no  compensation  paid during  either of the years ended  December 31,
2000 and 1999

None of the Company's current officers or directors receives or has received any
salary  from  Company  during the  preceding  five years.  The Company  does not
anticipate  entering  into  employment  agreements  with any of its  officers or
directors in the near future.  Directors do not receive  compensation  for their
services as directors and are not reimbursed for expenses  incurred in attending
board meeting.


Item 11 -  Security  Ownership  of  Management,  Certain  Beneficial  Owners and
Management

The following  table sets forth as of April 30, 2001,  the number and percentage
of the 152,247  outstanding  shares of common stock that were beneficially owned
by (i) each person who is  currently a director,  (ii) each  executive  officer,
(iii) all  current  directors  and  executive  officers as a group and (iv) each
person who, to the knowledge of the Company is the beneficial owner of more than
5% of the outstanding common stock. Except as otherwise  indicated,  the persons
named in the table have sole voting and  dispositive  power with  respect to all
shares beneficially owned, subject to community property laws where applicable.

Name and Address                       Common Shares       Percent of Class (1)
----------------                       -------------       --------------------

Glenn A. Little                        109,000             71.6%
211 W. Wall Street
Midland TX 79701

Matthew Blair                          0                   0.00%
211 W. Wall Street
Midland TX 79701

All officers and directors as a        109,000             71.6%
Group (2 persons)

(1)  Based on 152,247 shares outstanding as of April 30, 2001.


Item 12 - Certain Relationships and Related Transactions

The  Company's  President,  Glenn A. Little,  has agreed to provide funds to the
Company  sufficient  to cover  Company  expenses  relating  to its SEC  periodic
reporting and other minor corporate expenses.

Except for the transactions  described above there are no proposed  transactions
and no  transactions  during the past two years to which the Company was a party
and  in  which  any  officer,  director,  or  principal  stockholder,  or  their
affiliates or associates, was also a party.


Item 13 - Exhibits and Reports on Form 8-K

Copies of the  following  documents  are  included  as  exhibits  to this report
pursuant to Item 601 of Regulation S-B.

Exhibits
3.1   Articles of Incorporation, as amended (1)
3.2   By-Laws (1)

(1)   Incorporated  herein by this reference to the Company's  Current Report on
      Form 8-K  filed  with the U. S.  Securities  and  Exchange  Commission  on
      December 29, 1998.

                                                                               9



Form 8-K Filings
----------------

February 8, 1999        Announcement of a change of State of Incorporation  from
                        Florida  to Nevada and a change in  corporate  name from
                        DataLink   Capital   Corporation   to  DCC   Acquisition
                        Corporation.

June 11, 1999           Announcement of the acquisition of all of the issued and
                        outstanding  common  shares of New Cinema  Partners Inc.
                        ("NCP") in  consideration  of and in exchange for common
                        stock  of  the  Company   issued  from   treasury   (the
                        "Acquisition     Transaction"),     which    transaction
                        constituted a change in control of the Company.

August 5, 1999          Announcement that the Acquisition Transaction filed on a
                        Current  Report  on Form  8-K on June  11,  1999and  the
                        filing of the Form 8-K Current Report in respect thereof
                        were  premature.  The  Acquisition  Transaction  has not
                        been, and will not be, consummated.

January 10, 2000        Announcement of the  resignation of S. W. Hatfield,  CPA
                        as the Company's independent certified public accounting
                        firm

April 12, 2001          Announcement  of  the  premature   announcement  of  the
                        acquisition  of  ProHealth  Laboratories,  Inc.  and STL
                        Group,  Inc. and the acceptance of  reappointment as the
                        Company's  independent  certified public accounting firm
                        by S. W. Hatfield, CPA.

--------------------------------------------------------------------------------

                                   SIGNATURES

In accord with Section 13 or 15(d) of the  Securities  Act of 1993,  as amended,
the Company  caused  this report to be signed on its behalf by the  undersigned,
thereto duly authorized.

                                                    ProHealth Laboratories, Inc.

Dated: April 30, 2001                               By:      /s/ Glenn A. Little
       --------------                                  -------------------------

                                                                 Glenn A. Little
                                                         President, Director and
                                                         Chief Executive Officer

In accordance with the Securities Exchange Act of 1934, as amended, this report
has been signed below by the following persons on behalf of the Company and in
the capacities and on the date as indicated.

Dated: April 30, 2001                               By:     /s/ Glenn A. Little
       --------------                                  -------------------------

                                                                 Glenn A. Little
                                                         President, Director and
                                                         Chief Executive Officer


Dated: April 30, 2001                                 By:     /s/ Matthew Blair
       --------------                                    -----------------------

                                                                   Matthew Blair
                                                                        Director




                                                                              10



                                    PROHEALTH
                               LABORATORIES, INC.
                        (formerly DCC Acquisition Corp.)

                              Financial Statements
                                       and
                                Auditor's Report

                           December 31, 2000 and 1999





                               S. W. HATFIELD, CPA
                          certified public accountants

                      Use our past to assist your future sm




                          ProHealth Laboratories, Inc.
                        (formerly DCC Acquisition Corp.)

                                    Contents

                                                                            Page
                                                                            ----

Report of Independent Certified Public Accountants                           F-3

Financial Statements

   Balance Sheets
     as of December 31, 2000 and 1999                                        F-4

   Statements of Operations
     for the years ended December 31, 2000 and 1999                          F-5

   Statement of Changes in Shareholders' Equity
     for the years ended December 31, 2000 and 1999                          F-6

   Statements of Cash Flows
     for the years ended December 31, 2000 and 1999                          F-7

   Notes to Financial Statements                                             F-8







                                                                             F-2




S. W. HATFIELD, CPA
certified public accountants

Member:    American Institute of Certified Public Accountants
               SEC Practice Section
               Information Technology Section
           Texas Society of Certified Public Accountants



               REPORT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS
               --------------------------------------------------


Board of Directors and Stockholders
ProHealth Laboratories, Inc.
   (formerly DCC Acquisition Corp.)

We have audited the accompanying balance sheets of ProHealth Laboratories,  Inc.
(a  Nevada  corporation)  as of  December  31,  2000 and  1999  and the  related
statements of operations  and  comprehensive  income,  changes in  shareholders'
equity and cash flows for the each of the two years then ended.  These financial
statements   are  the   responsibility   of  the   Company's   management.   Our
responsibility  is to express an opinion on these financial  statements based on
our audits.

We  conducted  our  audits  in  accordance  with  generally   accepted  auditing
standards.  Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement.  An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements.  An audit also includes
assessing the  accounting  principles  used and  significant  estimates  made by
management,  as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.

In our opinion,  the financial  statements  referred to above present fairly, in
all material respects, the financial position of ProHealth Laboratories, Inc. as
of December  31,  2000 and 1999 and the related  statements  of  operations  and
comprehensive  income,  changes in  shareholders'  equity and cash flows for the
each  of the two  years  then  ended,  in  conformity  with  generally  accepted
accounting principles.

The  accompanying  financial  statements  have been  prepared  assuming that the
Company  will  continue  as a  going  concern.  As  discussed  in  Note A to the
financial statements, the Company has no viable operations or significant assets
and is dependent upon  significant  shareholders to provide  sufficient  working
capital to maintain the integrity of the corporate entity.  These  circumstances
create  substantial  doubt  about the  Company's  ability to continue as a going
concern and are discussed in Note A. The financial statements do not contain any
adjustments that might result from the outcome of these uncertainties.



                                                         S. W. HATFIELD, CPA
Dallas, Texas
April 23, 2001


                      Use our past to assist your future sm
(secure mailing address)                   (overnight delivery/shipping address)
P. O. Box 820395                               9002 Green Oaks Circle, 2nd Floor
Dallas, Texas  75382-0395                               Dallas, Texas 75243-7212
214-342-9635 (voice)                                          (fax) 214-342-9601
800-244-0639                                                      SWHCPA@aol.com
                                       F-3





                          ProHealth Laboratories, Inc.
                        (formerly DCC Acquisition Corp.)
                                 Balance Sheets
                           December 31, 2000 and 1999


                                                               2000         1999
                                                             ---------    ---------
                                                                    
                                     ASSETS
                                     ------
Current assets
   Cash on hand and in bank                                  $    --      $    --
                                                             ---------    ---------

   Total current assets                                           --           --
                                                             ---------    ---------

Total Assets                                                 $    --      $    --
                                                             =========    =========


                      LIABILITIES AND SHAREHOLDERS' EQUITY
                      ------------------------------------
Liabilities
   Current liabilities
     Accounts payable - trade                                $   1,283    $     963
                                                             ---------    ---------

     Total current liabilities                                   1,283          963
                                                             ---------    ---------


Commitments and contingencies


Shareholders' equity (deficit)
   Common stock - $0.0001 par value
     100,000,000 shares authorized
     152,247 and 145,640 shares
     issued and outstanding, respectively                           15           15
   Additional paid-in capital                                  811,182      805,782
   Accumulated deficit                                        (812,480)    (806,760)
                                                             ---------    ---------

   Total Shareholders' Equity (Deficit)                         (1,283)        (963)
                                                             ---------    ---------

   Total Liabilities and Shareholders' Equity                $    --      $    --
                                                             =========    =========




The accompanying notes are an integral part of these financial statements.
                                                                             F-4



                          ProHealth Laboratories, Inc.
                        (formerly DCC Acquisition Corp.)
                Statements of Operations and Comprehensive Income
                     Years ended December 31, 2000 and 1999


                                                   2000         1999
                                                 ---------    ----------

Revenues                                         $    --      $    --
                                                 ---------    ---------

Expenses
   General and administrative expenses               5,720        3,354
                                                 ---------    ---------

     Total operating expenses                        5,720        3,354
                                                 ---------    ---------

Income (Loss) from continuing operations
   before provision for income taxes                (5,720)      (3,354)

Provision for income taxes                            --           --
                                                 ---------    ---------

Net Income (Loss)                                   (5,720)      (3,354)

Other Comprehensive Income                            --           --
                                                 ---------    ---------

Comprehensive Income (Loss)                      $  (5,720)   $  (3,354)
                                                 =========    =========


Earnings per share of common stock
   outstanding computed on net loss -
   basic and fully diluted                       $   (0.04)   $   (0.02)
                                                 =========    =========

Weighted-average number of shares
   outstanding - basic and fully diluted           147,376      145,640
                                                 =========    =========




The accompanying notes are an integral part of these financial statements.
                                                                             F-5





                          ProHealth Laboratories, Inc.
                        (formerly DCC Acquisition Corp.)
                  Statement of Changes in Shareholders' Equity
                     Years ended December 31, 2000 and 1999



                                         Common Stock          Additional
                                         ------------            paid-in    Accumulated
                                     Shares        Amount        capital      deficit        Total
                                   ----------    ----------    ----------   ----------    ----------
                                                                           
Balances at January 1, 1999         1,456,097    $      146    $  798,029   $ (803,406)   $   (5,231)

Effect of November 1, 1999
   1 for 10 reverse stock split,
   including rounding              (1,310,457)         (131)          131         --            --
                                   ----------    ----------    ----------   ----------    ----------

Balances at January 1, 1999,
   as restated                        145,640            15       798,160     (803,406)       (5,231)

Advances from shareholder
   contributed as additional
   paid-in capital                       --            --           3,000         --           3,000

Capital contributed to
   support operations                    --            --           4,622         --           4,622

Net loss for the year                    --            --            --         (3,354)       (3,354)
                                   ----------    ----------    ----------   ----------    ----------

Balances at December 31, 1999         145,640            15       805,782     (806,760)         (963)

Common stock issued for
   payment of consulting fees           6,607          --           5,000         --           5,000

Capital contributed to
   support operations                    --            --             400         --             400

Net loss for the year                    --            --            --         (5,720)       (5,720)
                                   ----------    ----------    ----------   ----------    ----------

Balances at December 31, 2000         145,640    $       15    $  811,182   $ (812,480)   $   (1,283)
                                   ==========    ==========    ==========   ==========    ==========





The accompanying notes are an integral part of these financial statements.
                                                                             F-6



                          ProHealth Laboratories, Inc.
                        (formerly DCC Acquisition Corp.)
                            Statements of Cash Flows
                     Years ended December 31, 2000 and 1999


                                                            2000       1999
                                                            -------    -------
Cash Flows from Operating Activities
   Net income (loss) for the period                         $(5,720)   $(3,354)
   Adjustments to reconcile net loss
     to net cash provided by operating activities
       Common stock issued for consulting fees                5,000       --
       Increase (Decrease) in
         Accounts payable - trade                               320     (1,268)
                                                            -------    -------

Net cash used in operating activities                          (400)    (4,622)
                                                            -------    -------


Cash Flows from Investing Activities                           --         --
                                                            -------    -------


Cash Flows from Financing Activities
   Cash advanced by shareholder                                 400      4,622
                                                            -------    -------

Net cash provided by financing activities                       400      4,622
                                                            -------    -------

Increase (Decrease) in Cash                                    --         --

Cash at beginning of period                                    --         --
                                                            -------    -------

Cash at end of period                                       $  --      $  --
                                                            =======    =======

Supplemental Disclosure of Interest and Income Taxes Paid
     Interest paid for the year                             $  --      $  --
                                                            =======    =======
     Income taxes paid for the year                         $  --      $  --
                                                            =======    =======



The accompanying notes are an integral part of these financial statements.
                                                                             F-7



                          ProHealth Laboratories, Inc.
                        (formerly DCC Acquisition Corp.)

                          Notes to Financial Statements


Note A - Organization and Description of Business

ProHealth  Laboratories,  Inc. (Company) was originally  incorporated on January
26, 1983 under the laws of the State of Florida as Datalink  Systems,  Inc.  for
the  purpose  of  marketing  electronic  information  processing  systems to the
medical and  healthcare  industries.  As of December 31,  1986,  the Company had
closed this business operation.

The Company changed its corporate name to Datalink Capital  Corporation in April
1987 and to Midland Capital Resources,  Inc. in April 1991.  Subsequent thereto,
the  Company  forfeited  its  corporate  charter in the State of Florida  due to
non-payment  of various  taxes and fees. In July 1997,  the Company's  corporate
charter was reactivated with the State of Florida and changed its corporate name
to Datalink Capital Corporation, effective September 24, 1997.

On December  29,  1998,  the Company  changed  its State of  Incorporation  from
Florida  to  Nevada  by  means  of  a  merger  with  and  into  DCC  Acquisition
Corporation, a Nevada corporation formed solely for the purpose of effecting the
reincorporation.  The  Articles  of  Incorporation  and  Bylaws  of  the  Nevada
corporation  are the  Articles  of  Incorporation  and  Bylaws of the  surviving
corporation. Such Articles of Incorporation did not change the capital structure
of the Company and  effectively  changed the corporate  name to DCC  Acquisition
Corporation.

In November 1999, in anticipation  of a business  combination  transaction,  the
Company  experienced  a change in control.  As a result of the change in control
and the anticipated  business combination  transaction,  the Company changed its
corporate name to ProHealth  Laboratories,  Inc.  Subsequently,  the anticipated
business combination transaction did not occur.

The  Company  has  had  no  operations,   assets  or  liabilities   since  1989.
Accordingly,  the  Company  is  dependent  upon  management  and/or  significant
shareholders to provide  sufficient working capital to preserve the integrity of
the  corporate  entity  at  this  time.  It is  the  intent  of  management  and
significant  shareholders to provide  sufficient  working  capital  necessary to
support and preserve the integrity of the corporate entity. Through December 31,
2000, various Company  shareholders have advanced  approximately  $8,000 through
direct payments for operating expenses on behalf of the Company.

The Company follows the accrual basis of accounting in accordance with generally
accepted accounting principles and has a year-end of December 31.

The preparation of financial  statements in conformity  with generally  accepted
accounting principles requires management to make estimates and assumptions that
affect  the  reported  amounts  of assets  and  liabilities  and  disclosure  of
contingent  assets and  liabilities at the date of the financial  statements and
the  reported  amounts of revenues  and expenses  during the  reporting  period.
Actual results could differ from those estimates.


Note B - Summary of Significant Accounting Policies

1.   Cash and cash equivalents
     -------------------------

     For  Statement of Cash Flows  purposes,  the Company  considers all cash on
     hand  and  in  banks,  including  accounts  in  book  overdraft  positions,
     certificates of deposit and other highly-liquid investments with maturities
     of three months or less, when purchased, to be cash and cash equivalents.


                                                                             F-8



                          ProHealth Laboratories, Inc.
                        (formerly DCC Acquisition Corp.)

                    Notes to Financial Statements - Continued


Note B - Summary of Significant Accounting Policies - Continued

2.   Income Taxes
     ------------

     At December 31, 2000,  as a result of the November  1999 change in control,
     the Company has a net operating loss  carryforward  for income tax purposes
     of approximately  $3,400.  If this  carryforward is not fully utilized,  it
     will  begin  to  expire  in  2019.  As  of  December  31,  2000  and  1999,
     respectively, the deferred tax asset related to the Company's net operating
     loss carryforward is fully reserved.

3.   Earnings (loss) per share
     -------------------------

     Basic  earnings  (loss) per share is computed  by  dividing  the net income
     (loss) by the weighted-average  number of shares of common stock and common
     stock  equivalents  (primarily  outstanding  options and warrants).  Common
     stock equivalents  represent the dilutive effect of the assumed exercise of
     the  outstanding  stock  options and  warrants,  using the  treasury  stock
     method.  The calculation of fully diluted earnings (loss) per share assumes
     the dilutive effect of the exercise of outstanding  options and warrants at
     either the  beginning  of the  respective  period  presented or the date of
     issuance,   whichever  is  later.   As  of  December  31,  2000  and  1999,
     respectively, the Company had no warrants and/or options outstanding.


Note C - Fair Value of Financial Instruments

The carrying amount of cash,  accounts  receivable,  accounts  payable and notes
payable, as applicable,  approximates fair value due to the short term nature of
these items  and/or the current  interest  rates  payable in relation to current
market conditions.


Note D - Income Taxes

The components of income tax (benefit) expense  for the years ended December 31,
2000 and 1999, respectively, are as follows:
                                               December 31,   December 31,
                                                    1999           1999
                                               ------------   ------------
       Federal:
         Current                                  $     -        $     -
         Deferred                                       -              -
                                                  -------        -------
                                                        -              -
                                                  -------        -------
       State:
         Current                                        -              -
         Deferred                                       -              -
                                                  -------        -------
                                                        -              -
                                                  -------        -------

         Total                                    $     -        $     -
                                                  =======        =======


                                                                             F-9



                          ProHealth Laboratories, Inc.
                        (formerly DCC Acquisition Corp.)

                    Notes to Financial Statements - Continued


Note D - Income Taxes - Continued

As of December 31, 2000, as a result of the November 1999 change in control, the
Company has a net operating loss carryforward of approximately  $3,400 to offset
future taxable income.  Subject to current  regulations,  this carryforward will
begin to expire in 2019. The amount and  availability  of the net operating loss
carryforwards  may be subject to limitations  set forth by the Internal  Revenue
Code. Factors such as the number of shares ultimately issued within a three year
look-back  period;  whether  there is a deemed  more than 50  percent  change in
control; the applicable long-term tax exempt bond rate; continuity of historical
business;  and  subsequent  income  of the  Company  all enter  into the  annual
computation of allowable annual utilization of the carryforwards.

The Company's income tax expense for the years ended December 31, 2000 and 1999,
respectively, are as follows:

                                                     December 31,   December 31,
                                                          2000           1999
                                                     ------------   ------------
Statutory rate applied to loss before income taxes     $  (245)       $(1,140)
Increase (decrease) in income taxes resulting from:
     State income taxes                                      -              -
     Other, including reserve for deferred tax asset       245          1,140
                                                       -------        -------

       Income tax expense                              $     -        $     -
                                                       =======        =======

Temporary  differences,  consisting primarily of statutory deferrals of expenses
for organizational costs and statutory  differences in the depreciable lives for
property and equipment, between the financial statement carrying amounts and tax
bases of assets and liabilities give rise to deferred tax assets and liabilities
as of December 31, 2000 and 1999, respectively:

                                                     December 31,   December 31,
                                                          2000           1999
                                                     ------------   ------------
       Deferred tax assets
         Net operating loss carryforwards              $ 1,150        $ 1,033
         Less valuation allowance                       (1,150)        (1,033)
                                                       -------        -------

       Net Deferred Tax Asset                          $     -        $     -
                                                       =======        =======


Note E - Common Stock Transactions

On October  22,  1999,  effective  November  1,  1999,  the  Company's  Board of
Directors approved and enacted a 1:10 reverse split of its Common Stock, $0.0001
par value,  with  fractional  shares rounded up to the nearest whole share.  The
accompanying financial statements reflect this action as of the first day of the
first period presented.

On July 21, 2000,  the Company  issued an aggregate  6,607 shares of restricted,
unregistered  common stock in payment of consulting  fees. This  transaction was
valued at approximately  $5,000, which approximates the "fair value" of both the
common stock issued, based on the closing price of the last trade date preceding
the issue date, and the estimated value of the services rendered to the Company.



                                                                            F-10





                          ProHealth Laboratories, Inc.
                        (formerly DCC Acquisition Corp.)

                    Notes to Financial Statements - Continued


Note F - Selected Financial Data (Unaudited)

The following is a summary of the quarterly  results of operations for the years
ended December 31, 2000 and 1999, respectively.

                              Quarter ended  Quarter ended  Quarter ended  Quarter ended   Year ended
                                March 31        June 30      September 30   December 31    December 31
                              -------------  -------------  -------------  -------------  -------------
                                                                           
2000
----
   Net revenues                 $    --        $    --        $    --        $    --        $    --
   Gross profit                      --             --             --             --             --
   Net loss from operations          (222)          (159)        (5,180)          (159)        (5,720)
   Basic and fully diluted
     earnings per share               nil            nil            nil            nil            nil
   Weighted-average
     number of shares
     outstanding                  145,640        145,640        150,811        152,247        147,376

1999
----
   Net revenues                 $    --        $    --        $    --        $    --        $    --
   Gross profit                      --             --             --             --             --
   Net loss from operations          (159)          (158)          --           (3,037)        (3,354)
   Basic and fully diluted
     earnings per share               nil            nil            nil            nil            nil
   Weighted-average
     number of shares
     outstanding                  145,640        145,640        145,640        145,640        145,640






                                                                            F-11